...STARPegBio Co. Ltd. raised around RMB800 million ($121.6 million) in a pre-IPO round co-led by Yunfeng Capital...

...between the company and its shareholders, which include Chinese venture capital firms 3W Partners and Yunfeng Capital...

...led by Ireland Strategic Investment Fund, which contributed $70 million, and included existing investors Temasek, Yunfeng Capital...

...led by Ireland Strategic Investment Fund, which contributed $70 million, and included existing investors Temasek, Yunfeng Capital...

...Biodesix Inc. Integrated Diagnostics Inc. 7/9/18 ND ND ND Hybio Pharmaceutical Co. Ltd. (SZSE:300199) / Yunfeng Capital...

...He said the $260 million in committed capital from Arch, 6 Dimensions Capital, Boyu Capital, Yunfeng Capital...

...through commercialization and market access. Arch, 6 Dimensions Capital and Boyu Capital led the round. Yunfeng Capital...

...through commercialization and market access. Arch, 6 Dimensions Capital and Boyu Capital led the round. Yunfeng Capital...

...CStone’s untranched $260 million financing, which closed on May 9. Fellow new investors Sequoia China, Yunfeng Capital...

...series B ever for a Chinese biopharma. New investors in the round included Sequoia China, Yunfeng Capital...